1 Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. JU Jensen, L Hein, B Lundgren, MH Bestle, TT Mohr, MH Andersen, KJ Thornberg, J Løken, M Steensen, Z Fox, H Tousi, P Søe-Jensen, AØ Lauritsen, D Strange, PL Petersen, N Reiter, S Hestad, K Thormar, P Fjeldborg, KM Larsen, NE Drenck, C Ostergaard, J Kjær, J Grarup, JD Lundgren; Procalcitonin And Survival Study (PASS) Group.
Crit Care Med. 2011 Sep;39(9):2048-58. abstract
2 The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. JU Jensen, B Lundgren, L Hein, T Mohr, PL Petersen, LH Andersen, AO Lauritsen, S Hougaard, T Mantoni, B Bømler, KJ Thornberg, K Thormar, J Løken, M Steensen, P Carl, JA Petersen, H Tousi, P Søe-Jensen, M Bestle, S Hestad, MH Andersen, P Fjeldborg, KM Larsen, C Rossau, CB Thomsen, C Ostergaard, J Kjaer, J Grarup, JD Lundgren.
BMC Infect Dis. 2008 Jul 13;8:91. abstract
3 Procalcitonin in liver transplant patients - yet another stone turned. JU Jensen, JD Lundgren.
Crit Care. 2008;12(1):108. Epub 2008 Jan 22 abstract
4 Meta-analysis of procalcitonin for sepsis detection. JU Jensen, B Lundgren, JD Lundgren.
Lancet Infect Dis. 2007 Aug;7(8) abstract
5 Dynamic use of procalcitonin in the intensive care unit. JU Jensen, L Hein, K Thornberg, J Loeken, H Tousi, KM Larsen, MH Andersen, M Bestle, T Mohr.
Int J Intensive Care. 2007;14(2):52-57
6 Procalcitonin in the Intensive Care Unit: Nice to know, Need to know or Needs further research. JU Jensen, J Loeken, TT Mohr
International Symposium on Intensive Care and Emergency Medicine (ISICEM), 27th Yearbook. Editor: JL Vincent, ISICEM, Brussels March 2007.
7 Procalcitonin increase in early identification of critically ill patients at high risk of mortality. JU Jensen, L Heslet, TH Jensen, K Espersen, P Steffensen, M Tvede.
Crit Care Med. 2006 Oct;34(10):2596-602 abstract
8 Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial. JU Jensen, L Hein, B Lundgren, MH Bestle, T Mohr, MH Andersen, KJ Thornberg, J Løken, M Steensen, Z Fox, H Tousi, P Søe-Jensen, AØ Lauritsen, DG Strange, N Reiter, K Thormar, PC Fjeldborg, KM Larsen, NE Drenck, ME Johansen, LR Nielsen, C Ostergaard, J Kjær, J Grarup, JD Lundgren; Procalcitonin And Survival Study (PASS) Group.
BMJ Open. 2012 Mar 11;2(2):e000635. Print 2012. abstract